Quarterly report pursuant to Section 13 or 15(d)

Temporary Equity and Stockholders' Deficiency - Schedule of Share-based Compensation, Equity Instruments Other Than Options, by Exercise Price Range (Details)

v3.19.1
Temporary Equity and Stockholders' Deficiency - Schedule of Share-based Compensation, Equity Instruments Other Than Options, by Exercise Price Range (Details)
3 Months Ended
Mar. 31, 2019
$ / shares
shares
Warrants [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Warrants Outstanding, Number of Warrants 1,132,609
Warrants Exercisable, Number of Warrants 1,132,609
Range of Exercise Price 2.00 [Member] | Common Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Warrants Outstanding, Exercise Price | $ / shares $ 2.00
Warrants Outstanding Exercisable, Description Common Stock
Warrants Outstanding, Number of Warrants 741,879
Warrants Exercisable, Weighted Average Remaining Life in Years 1 year 9 months 18 days
Warrants Exercisable, Number of Warrants 741,879
Range of Exercise Price 2.30 [Member] | Common Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Warrants Outstanding, Exercise Price | $ / shares $ 2.30
Warrants Outstanding Exercisable, Description Common Stock
Warrants Outstanding, Number of Warrants 202,423
Warrants Exercisable, Weighted Average Remaining Life in Years 4 months 24 days
Warrants Exercisable, Number of Warrants 202,423
Range of Exercise Price 2.50 [Member] | Common Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Warrants Outstanding, Exercise Price | $ / shares $ 2.50
Warrants Outstanding Exercisable, Description Common Stock
Warrants Outstanding, Number of Warrants 188,307
Warrants Exercisable, Weighted Average Remaining Life in Years 2 years
Warrants Exercisable, Number of Warrants 188,307